| 000 | 01890 a2200553 4500 | ||
|---|---|---|---|
| 005 | 20250517205213.0 | ||
| 264 | 0 | _c20180917 | |
| 008 | 201809s 0 0 eng d | ||
| 022 | _a1177-8881 | ||
| 024 | 7 |
_a10.2147/DDDT.S156492 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKang, Woo Youl | |
| 245 | 0 | 0 |
_aPharmacokinetic and bioequivalence study of a telmisartan/S-amlodipine fixed-dose combination (CKD-828) formulation and coadministered telmisartan and S-amlodipine in healthy subjects. _h[electronic resource] |
| 260 |
_bDrug design, development and therapy _c2018 |
||
| 300 |
_a545-553 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAmlodipine _xadministration & dosage |
| 650 | 0 | 4 |
_aBenzimidazoles _xadministration & dosage |
| 650 | 0 | 4 |
_aBenzoates _xadministration & dosage |
| 650 | 0 | 4 | _aChromatography, Liquid |
| 650 | 0 | 4 | _aCross-Over Studies |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDrug Combinations |
| 650 | 0 | 4 | _aDrug Tolerance |
| 650 | 0 | 4 | _aHealthy Volunteers |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aMolecular Structure |
| 650 | 0 | 4 | _aStructure-Activity Relationship |
| 650 | 0 | 4 | _aTablets |
| 650 | 0 | 4 | _aTandem Mass Spectrometry |
| 650 | 0 | 4 | _aTelmisartan |
| 650 | 0 | 4 | _aTherapeutic Equivalency |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aSeong, Sook Jin | |
| 700 | 1 | _aOhk, Boram | |
| 700 | 1 | _aGwon, Mi-Ri | |
| 700 | 1 | _aKim, Bo Kyung | |
| 700 | 1 | _aLa, Sookie | |
| 700 | 1 | _aKim, Hyun-Ju | |
| 700 | 1 | _aCho, Seungil | |
| 700 | 1 | _aYoon, Young-Ran | |
| 700 | 1 | _aYang, Dong Heon | |
| 700 | 1 | _aLee, Hae Won | |
| 773 | 0 |
_tDrug design, development and therapy _gvol. 12 _gp. 545-553 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2147/DDDT.S156492 _zAvailable from publisher's website |
| 999 |
_c28199050 _d28199050 |
||